Additionally, we evaluated the combined effect of IGF-I and IGFBP-3 on pancreatic cancer risk by categorizing the plasma markers into tertiles and constructing a 3 × 3 table. This evidence concerns the gene IGF1 and familial pancreatic carcinoma.